Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOVE
2501
LoveSac
LOVE
$262M
| $3.73M | ﹤0.01% |
142,210
+1,230
| +0.9% | +$18.7K |
|
|
CFB
2502
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $3.72M | ﹤0.01% |
380,029
+39,902
| +12% | +$365K |
|
|
CHUY
2503
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $3.69M | ﹤0.01% |
248,181
+944
| +0.4% | +$14.1K |
|
|
CBAY
2504
DELISTED
Cymabay Therapeutics
CBAY
| $3.69M | ﹤0.01% |
1,056,003
-31,180
| -3% | -$90K |
|
2505
SunCoke Energy
SXC
$741M
| $3.68M | ﹤0.01% |
1,243,486
+97,881
| +9% | +$313K |
|
|
GTT
2506
DELISTED
GTT Communications, Inc.
GTT
| $3.63M | ﹤0.01% |
445,285
+8,882
| +2% | +$80.2K |
|
2507
Forestar Group
FOR
$1.49B
| $3.63M | ﹤0.01% |
240,394
+12,418
| +5% | +$171K |
|
|
VRAY
2508
DELISTED
ViewRay, Inc.
VRAY
| $3.62M | ﹤0.01% |
1,617,127
+36,435
| +2% | +$77.8K |
|
2509
Verastem
VSTM
$509M
| $3.6M | ﹤0.01% |
174,659
+90,887
| +108% | +$2.4M |
|
2510
Blue Bird Corp
BLBD
$2.43B
| $3.59M | ﹤0.01% |
239,502
+5,440
| +2% | +$68.2K |
|
2511
XBiotech
XBIT
$68.9M
| $3.59M | ﹤0.01% |
261,661
-14,997
| -5% | -$211K |
|
2512
Dorian LPG
LPG
$1.89B
| $3.57M | ﹤0.01% |
461,831
+59,773
| +15% | +$495K |
|
2513
Seneca Foods Class A
SENEA
$1.17B
| $3.57M | ﹤0.01% |
105,534
+1,676
| +2% | +$58.9K |
|
2514
IMAX
IMAX
$2.77B
| $3.56M | ﹤0.01% |
317,559
+3,256
| +1% | +$38.1K |
|
2515
SiTime
SITM
$17.5B
| $3.56M | ﹤0.01% |
75,046
+37,692
| +101% | +$1.12M |
|
|
CNCE
2516
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.55M | ﹤0.01% |
356,913
+19,633
| +6% | +$188K |
|
|
RUBY
2517
DELISTED
Rubius Therapeutics, Inc
RUBY
| $3.55M | ﹤0.01% |
593,283
+42,122
| +8% | +$249K |
|
2518
Anavex Life Sciences
AVXL
$295M
| $3.54M | ﹤0.01% |
720,725
+3,144
| +0.4% | +$11.9K |
|
2519
Franklin Covey
FC
$245M
| $3.53M | ﹤0.01% |
164,835
+21,934
| +15% | +$445K |
|
|
BLDP
2520
Ballard Power Systems
BLDP
$847M
| $3.52M | ﹤0.01% |
228,723
+16,379
| +8% | +$179K |
|
2521
Citi Trends
CTRN
$599M
| $3.52M | ﹤0.01% |
174,032
-924
| -0.5% | -$12.1K |
|
2522
Seres Therapeutics
MCRB
$51.2M
| $3.51M | ﹤0.01% |
36,906
+3,820
| +12% | +$335K |
|
2523
Civista Bancshares
CIVB
$604M
| $3.5M | ﹤0.01% |
227,467
+4,128
| +2% | +$60K |
|
2524
KRONOS Worldwide
KRO
$713M
| $3.49M | ﹤0.01% |
335,576
+3,074
| +0.9% | +$28.8K |
|
|
AKRO
2525
DELISTED
Akero Therapeutics
AKRO
| $3.49M | ﹤0.01% |
139,967
+26,060
| +23% | +$596K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.